Aims and scope
Particle and Fibre Toxicology is an open access, peer-reviewed, online multi-disciplinary journal for new scientific data, hypotheses and reviews on the toxicological effects of particles and fibres; it functions as a forum for scientific debate and communication among toxicologists as well as scientists from other disciplines that produce and develop particle and fibre materials, including material sciences, biomaterials and nanomedicine.
Particle and Fibre Toxicology is a multi-disciplinary journal focused on understanding the physico-chemistry of the particles, the possibilities for human exposure and biological outcomes, and regulatory issues in the workplace and general environment. In addition, there are diverse scenarios where particles may pose a toxicological threat due to new applications of old materials or introduction of new materials. Particle and Fibre Toxicology provides a single, identifiable outlet for output from all these disciplines.
Particle and Fibre Toxicology may also consider papers from the adjacent fields such as exposure sciences including dosimetry, biodistribution and register-based epidemiological studies. Submission of experimental papers primarily dealing with– omics data or single dose studies is not encouraged.
Particles and fibres are toxicologically important in many scenarios, including exposure:
- during the manufacture or use of classical industrial products such as pigments and (vitreous) fibres;
- to particles from disturbing the earth's crust during mining and quarrying;
- from general anthropogenic sources in the environment such as PM10, cigarette smoke, biomass and liquid fuel combustion;
- to nanomaterials that have been specifically engineered for special purposes, including for drug delivery and imaging.
Please contact the editor if you are in any doubt that the manuscript is in scope for Particle and Fibre Toxicology. If you wish to submit an epidemiological study, please contact us prior to submission with a submission enquiry (contact details below).
All articles published by Particle and Fibre Toxicology are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.
As authors of articles published in Particle and Fibre Toxicology you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the BioMed Central license agreement.
For those of you who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed.
Open access publishing is not without costs. Particle and Fibre Toxicology therefore levies an article-processing charge of £2170.00/$3170.00/€2570.00 for each article accepted for publication, plus VAT or local taxes where applicable.
If the corresponding author's institution participates in our open access membership program, some or all of the publication cost may be covered (more details available on the membership page). We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page.
BMC provides a free open access funding support service to help authors discover and apply for article processing charge funding. Visit our OA funding and policy support page to view our list of research funders and institutions that provide funding for APCs, and to learn more about our email support service.
All articles published in Particle and Fibre Toxicology are included in:
- Biological Abstracts
- Current contents
- PubMed Central
- Science Citation Index
- Science Citation Index Expanded
The full text of all articles is deposited in digital archives around the world to guarantee long-term digital preservation. You can also access all articles published by BioMed Central on SpringerLink.
Particle and Fibre Toxicology operates a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous. The benefit of single-blind peer review is that it is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.
Submitted manuscripts will generally be reviewed by two or more experts who will be asked to evaluate whether the manuscript is scientifically sound and coherent, whether it duplicates already published work, and whether or not the manuscript is sufficiently clear for publication. The Editors will reach a decision based on these reports and, where necessary, they will consult with members of the Editorial Board.
All manuscripts submitted to Particle and Fibre Toxicology should adhere to BioMed Central's editorial policies.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Appeals and complaints
If you wish to appeal a rejection or make a complaint you should, in the first instance, contact the Editor who will provide details of the journal's complaints procedure. For complaints that cannot be resolved with the Editor, the authors should contact the Publisher.
Citing articles in Particle and Fibre Toxicology
Articles in Particle and Fibre Toxicology should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.
Article citations follow this format:
Authors: Title. Part Fibre Toxicol [year], [volume number]:[article number].
e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Part Fibre Toxicol 2009, 1:115.
refers to article 115 from Volume 1 of the journal.
Why publish your article in Particle and Fibre Toxicology
Particle and Fibre Toxicology's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience.
Speed of publication
Particle and Fibre Toxicology offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF.
Online publication in Particle and Fibre Toxicology gives you the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).
Promotion and press coverage
Articles published in Particle and Fibre Toxicology are included in article alerts and regular email updates. Some may be highlighted on Particle and Fibre Toxicology’s pages and on the BioMed Central homepage.
In addition, articles published in Particle and Fibre Toxicology may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Particle and Fibre Toxicology. A list of articles recently press-released by journals published by BioMed Central is available here.
As an author of an article published in Particle and Fibre Toxicology you retain the copyright of your article and you are free to reproduce and disseminate your work (for further details, see the BioMed Central license agreement).
For further information about the advantages of publishing in a journal from BioMed Central, please click here.
Annual Journal Metrics
64 days to first decision for reviewed manuscripts only
53 days to first decision for all manuscripts
140 days from submission to acceptance
18 days from acceptance to publication
239 Altmetric mentions